bioAffinity Technologies, Inc. ( BIAF) - Stock Earnings
BIAF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 18, 2026, midnight | — / — | — | — / — | — |
BIAF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -3.1 million USD | 1.6 million USD |
| 2026Q1 | -3.6 million USD | 1.4 million USD |
| 2026Q2 | -3.4 million USD | 1.5 million USD |
| 2026Q4 Est. | — | — |
BIAF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -7.9 million USD | 2.5 million USD |
| 2024 | -9.0 million USD | 9.4 million USD |
| 2025 | -14.9 million USD | 6.2 million USD |
| 2026 Est. | — | — |
BIAF
Price: $2.80
52 week price:
Earnings Per Share: -1.35 USD
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 2.5 million